Bellander T, Osterdahl B G, Hagmar L, Skerfving S
Institute of Environmental Health, University of Lund, Sweden.
Int Arch Occup Environ Health. 1988;60(1):25-9. doi: 10.1007/BF00409375.
Piperazine has been shown to nitrosate in vivo to N-mononitrosopiperazine (MNPZ) by oral intake. Urine from workers exposed to piperazine in a chemical plant was analysed for nitrosamines by gas chromatography-thermal energy analysis. In five out of 11 exposed cases, MNPZ excretion in urine was 0.3 to 4.7 micrograms/24 h (during and after a work shift). In four cases, MNPZ was detected in some urine samples, and in two cases MNPZ was not detected (less than 0.1 ng/ml). The individual excretion was strongly dependent on piperazine exposure, which ranged from 0.06 to 1.7 mg/m3 (time-weighted average; Spearman's rank correlation 0.78, P = 0.01). The MNPZ excretion showed no significant correlation with nitrite or nitrate in saliva (both: r = 0.50, P = 0.10).
已证实哌嗪经口服摄入后在体内会亚硝化生成N-单亚硝基哌嗪(MNPZ)。通过气相色谱 - 热能分析对一家化工厂中接触哌嗪的工人尿液中的亚硝胺进行了分析。在11例接触者中,有5例在工作班次期间及之后尿液中MNPZ的排泄量为0.3至4.7微克/24小时。在4例中,在一些尿液样本中检测到了MNPZ,在2例中未检测到MNPZ(低于0.1纳克/毫升)。个体排泄量强烈依赖于哌嗪暴露量,暴露量范围为0.06至1.7毫克/立方米(时间加权平均值;斯皮尔曼等级相关性为0.78,P = 0.01)。MNPZ排泄量与唾液中亚硝酸盐或硝酸盐无显著相关性(两者:r = 0.50,P = 0.10)。